AN2 Therapeutics Inc

AN2 Therapeutics Inc (ANTX) Price Prediction & Forecast

$3.955

-0.274 (-6.94%)At close

Price Predictions

1-Day Price Prediction
-0.18%
1-Week Prediction
-0.65%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

Open in app to unlock longer-horizon forecasts.

Loading chart…

ANTX Prediction & Forecast by Similar Chart Analysis

Alphio's ANTX stock price prediction model matches the current AN2 Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.95 (-0.18%). The 1-week path is $3.93 (-0.65%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy AN2 Therapeutics Inc Stock?

ANTX is a good buy right now due to its recent FDA clearance for the epetraborole drug, which is expected to drive future growth. The current price is $4.35, significantly below the analyst target of $9, suggesting a potential upside of over 100%. Additionally, the stock has shown a strong year-to-date change of +291.89%, indicating robust momentum. However, a risk to consider is the company's ongoing net losses, which reached $10.03 million in Q1 2026, reflecting the need for continued investment in R&D.

ANTX stock price ended at $3.95 on Thursday, after losing -6.94%

AN2 Therapeutics Inc (ANTX) last closed at $3.9549999, losing -6.94%. These facts feed the 1-day and 1-week ANTX price prediction above.

Forecast Drivers

AN2 Therapeutics Inc (ANTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

Similar Chart Patterns

Stocks whose recent price path most closely matches ANTX, ranked by similarity.

Seasonality analysis for ANTX

Historically the probability of a positive November return for ANTX is 9.30%. March offers the highest probability of a positive month at 47.62%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading